Rodman & Renshaw Cuts Medivation (MDVN) to Market Underperform, Sets $13 Price Target
Tweet Send to a Friend
An analyst at Rodman & Renshaw downgraded shares of Medivation (Nasdaq: MDVN) from Market Perform to Market Underperform Monday morning ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


